Skip to main content

4 Result(s)

within Meydan Ben Ishai Remove this filter Medicine/Public Health, general Remove this filter

and

  1. No Access

    Article

    Primary cemiplimab treatment for orbital squamous cell carcinoma is effective and may alleviate the need for orbital exenteration

    To evaluate the effectiveness of cemiplimab, a Programmed-cell-death-1(PD-1) protein inhibitor, for the treatment of cutaneous periocular-locally-advanced squamous-cell-carcinoma (POLA-SCC) with orbital-invasion.

    Alon Tiosano, Meydan Ben-Ishai, Yaacov Cnaany, Gal Markel, Noga Kurman… in Eye (2023)

  2. No Access

    Article

    The initial rate of tumour response to vismodegib treatment, can predict a complete response outcome for periocular LA-BCC

    To establish a model to predict treatment outcome of periocular locally advanced basal cell carcinoma (POLA BCC) based on initial response to treatment with vismodegib (ErivedgeTM), a sonic hedgehog inhibitor.

    Alon Tiosano, Meydan Ben-Ishai, Eyal Fenig, Guy J. Ben simon, Iftach Yassur in Eye (2023)

  3. No Access

    Article

    Limbal–conjunctival autograft healing process—early postoperative OCT angiography study

    To assess the normal healing process of limbal–conjunctival autograft (LCA) after pterygium removal during the early postoperative period using anterior segment optical coherence tomography angiography (OCTA).

    Yariv Keshet, Asaf Polat, Orly Gal-Or, Meydan Ben Ishai, Yotam Keshet… in Eye (2022)

  4. No Access

    Article

    Vismodegib improves quality of life in patients with periocular locally advanced basal cell carcinoma: subgroup analysis, STEVIE trial

    To evaluate the effect of locally advanced periocular basal cell carcinoma (POLA-BCC) on health-related quality of life (HRQoL) and the benefit of vismodegib treatment among participants in the Safety Events i...

    Assaf Gershoni, Alon Tiosano, Meydan Ben Ishai, Edward Barayev, Guy J. Ben Simon… in Eye (2022)